We are live on ! Find out more
First Manhattan

First Manhattan Portfolio holdings

AUM $36.1B
1-Year Est. Return 11.5%
This Fund
S&P 500
This Quarter Est. Return
+11.24%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$3.67B
Cap. Flow
+$1.33B
Cap. Flow %
4.86%
Top 10 Hldgs %
61.8%
Holding
1,839
New
200
Increased
397
Reduced
428
Closed
156

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$117M
2
BN icon
Brookfield
BN
+$117M
3
META icon
Meta Platforms (Facebook)
META
+$70.7M
4
AMZN icon
Amazon
AMZN
+$62.2M
5
DPZ icon
Domino's
DPZ
+$56.1M

Sector Composition

Rank Sector Weight
1 Financials 49.2%
2 Technology 13.2%
3 Healthcare 10.72%
4 Consumer Discretionary 7.69%
5 Communication Services 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLVP icon
1651
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$805M
$21 ﹤0.01%
2
CVM icon
1652
CEL-SCI Corp
CVM
$20.6M
0
AUROW
1653
Aurora Innovation Warrant
AUROW
$13 ﹤0.01%
100
CPUH.WS
1654
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$12 ﹤0.01%
110
TTOO
1655
DELISTED
T2 Biosystems, Inc
TTOO
0
FTEK icon
1656
Fuel Tech
FTEK
$48M
$10 ﹤0.01%
8
FATH.WS
1657
DELISTED
Fathom Digital Manufacturing Corporation Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50 per share
FATH.WS
$9 ﹤0.01%
110
ACB
1658
Aurora Cannabis
ACB
$165M
$7 ﹤0.01%
1
-1
-50% -$12
GRDX
1659
GridAI Technologies Corp
GRDX
$21.3M
0
MTVC.WS
1660
DELISTED
Motive Capital Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
MTVC.WS
$4 ﹤0.01%
100
LDTCW
1661
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
$3 ﹤0.01%
200
CYRN
1662
DELISTED
CYREN Ltd.
CYRN
$3 ﹤0.01%
5
SVFAW
1663
DELISTED
SVF Investment Corp. Warrant
SVFAW
$2 ﹤0.01%
100
ACES icon
1664
ALPS Clean Energy ETF
ACES
$109M
-504
Closed -$27K
ADCT icon
1665
ADC Therapeutics
ADCT
$146M
-200
Closed
ADNT icon
1666
Adient
ADNT
$1.6B
-14
Closed
AI icon
1667
C3.ai
AI
$1.27B
-80
Closed -$1K
AMBP icon
1668
Ardagh Metal Packaging
AMBP
$2.86B
-200
Closed
AMG icon
1669
Affiliated Managers Group
AMG
$9.46B
-127
Closed -$14K
AOUT icon
1670
American Outdoor Brands
AOUT
$162M
-725
Closed -$6K
APLT
1671
DELISTED
Applied Therapeutics
APLT
-73,783
Closed -$68K
APP icon
1672
Applovin
APP
$132B
-100
Closed -$1K
ARCT icon
1673
Arcturus Therapeutics
ARCT
$157M
-200
Closed -$2K
ARKF icon
1674
ARK Blockchain & Fintech Innovation ETF
ARKF
$718M
-57
Closed
AUR icon
1675
Aurora
AUR
$11.7B
-800
Closed -$1K

Similar funds

First Manhattan's Q4 2022 Portfolio in Review

As of Q4 2022, First Manhattan held 1,839 positions worth $27.3B, up 16% from $23.6B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

First Manhattan deployed $1.33B of net new capital in Q4 2022, opening 200 new positions and adding to 397 existing holdings. Its largest new stake was Brookfield Asset Management: 3,875,454 shares worth $111M.

By sector, the portfolio is most concentrated in Financials at 49% of assets, up from 44% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $117M trimmed.

  • First Manhattan's largest Q4 2022 buy was Brookfield Asset Management: 3,875,454 shares worth $111M.
  • First Manhattan added most to Berkshire Hathaway Class A in Q4 2022, an estimated $1.63B increase.
  • First Manhattan's biggest Q4 2022 reduction was Apple, cutting an estimated $117M.
  • First Manhattan fully exited Alleghany Corp in Q4 2022, selling an estimated $1.07M.
  • First Manhattan's ten largest holdings make up 62% of its $27.3B portfolio in Q4 2022.
  • First Manhattan opened 200 new positions and closed 156 in Q4 2022.
  • First Manhattan's portfolio value rose 16% quarter-over-quarter to $27.3B.

Based on First Manhattan's 13F filing for Q4 2022, filed 14 Feb 2023.